Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial.

Stelljes M, Middeke JM, Bug G, Wagner-Drouet EM, Müller LP, Schmid C, Krause SW, Bethge W, Jost E, Platzbecker U, Klein SA, Schubert J, Niederland J, Kaufmann M, Schäfer-Eckart K, Schaich M, Baldauf H, Stölzel F, Petzold C, Röllig C, Alakel N, Steffen B, Hauptrock B, Schliemann C, Sockel K, Lang F, Kriege O, Schaffrath J, Reicherts C, Berdel WE, Serve H, Ehninger G, Schmidt AH, Bornhäuser M, Mikesch JH, Schetelig J, Study Alliance Leukemia and the German Cooperative Transplant Study Group

Open source

DOI: 10.1016/s2352-3026(24)00065-6
Published: 2024 May
Container: The Lancet. Haematology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2352-3026-24-00065-6,
  title = {Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial.},
  author = {Stelljes M and Middeke JM and Bug G and Wagner-Drouet EM and Müller LP and Schmid C and Krause SW and Bethge W and Jost E and Platzbecker U and Klein SA and Schubert J and Niederland J and Kaufmann M and Schäfer-Eckart K and Schaich M and Baldauf H and Stölzel F and Petzold C and Röllig C and Alakel N and Steffen B and Hauptrock B and Schliemann C and Sockel K and Lang F and Kriege O and Schaffrath J and Reicherts C and Berdel WE and Serve H and Ehninger G and Schmidt AH and Bornhäuser M and Mikesch JH and Schetelig J and Study Alliance Leukemia and the German Cooperative Transplant Study Group},
  year = {2024},
  journal = {The Lancet. Haematology},
  doi = {10.1016/s2352-3026(24)00065-6},
  url = {https://doi.org/10.1016/s2352-3026(24)00065-6}
}

RIS

TY  - JOUR
TI  - Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial.
AU  - Stelljes M
AU  - Middeke JM
AU  - Bug G
AU  - Wagner-Drouet EM
AU  - Müller LP
AU  - Schmid C
AU  - Krause SW
AU  - Bethge W
AU  - Jost E
AU  - Platzbecker U
AU  - Klein SA
AU  - Schubert J
AU  - Niederland J
AU  - Kaufmann M
AU  - Schäfer-Eckart K
AU  - Schaich M
AU  - Baldauf H
AU  - Stölzel F
AU  - Petzold C
AU  - Röllig C
AU  - Alakel N
AU  - Steffen B
AU  - Hauptrock B
AU  - Schliemann C
AU  - Sockel K
AU  - Lang F
AU  - Kriege O
AU  - Schaffrath J
AU  - Reicherts C
AU  - Berdel WE
AU  - Serve H
AU  - Ehninger G
AU  - Schmidt AH
AU  - Bornhäuser M
AU  - Mikesch JH
AU  - Schetelig J
AU  - Study Alliance Leukemia and the German Cooperative Transplant Study Group
PY  - 2024
JO  - The Lancet. Haematology
DO  - 10.1016/s2352-3026(24)00065-6
UR  - https://doi.org/10.1016/s2352-3026(24)00065-6
ER  -

APA

M, S., JM, M., G, B., EM, W., LP, M., C, S., SW, K., W, B., E, J., U, P., SA, K., J, S., J, N., M, K., K, S., M, S., H, B., F, S., C, P., C, R., N, A., B, S., B, H., C, S., K, S., F, L., O, K., J, S., C, R., WE, B., H, S., G, E., AH, S., M, B., JH, M., J, S., & Group, S. A. L. A. T. G. C. T. S. (2024). Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial.. The Lancet. Haematology. https://doi.org/10.1016/s2352-3026(24)00065-6

Source records

pubmed · retrieved 2026-09-26T20:26:05.786Z